HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up
- PMID: 17465003
- DOI: 10.1002/hep.21612
HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up
Abstract
Spontaneous hepatitis B surface antigen (HBsAg) seroclearance in chronic HBV infection has long been suggested as a rare event in high endemic areas. The prevalence of HBsAg in the general population of Taiwan, however, decreased remarkably from 15%-20% before age 40 to 5%-10% after age 60 or 70. This study aimed to reexamine the rates of HBsAg seroclearance by a long-term follow-up of 1965 hepatitis B e antibody-positive asymptomatic adult carriers. Of these, 1076 (55%) were males, the mean (+/-SD) age was 35.6+/-9.2 years and the mean follow-up was 10.8+/-5.4 years. Hepatitis relapsed in 314 patients, 0.5 to 18 (mean+/-SD=5.8+/-4.4) years after the entry. The probability of hepatitis relapse correlated positively with male sex (P<0.0001) and age at entry (P<0.0001). Serum HBsAg cleared in 245 patients at the mean age of 47.8+/-9.6 years. The cumulative probabilities of HBsAg seroclearance were 8.1% after 10 years, but increased disproportionally to 24.9% and 44.7%, respectively, after 20 and 25 years. In multivariate analysis, the probability of HBsAg seroclearance correlated positively with age at entry (P<0.0001) and sustained remission of hepatitis (P<0.0001) and marginally significantly with male sex (P=0.053).
Conclusion: Cumulative rate of HBsAg seroclearance in asymptomatic adult carriers from high endemic areas was approximately 40% after 25 years of follow-up. The low HBsAg seroclearance rates in previous studies might be due to the relative short period of follow-up.
Comment in
-
Spontaneous hepatitis B surface antigen seroclearance confers appreciably high rates except in patients with relapse of hepatitis.Hepatology. 2008 Sep;48(3):1021-2; author reply 1022. doi: 10.1002/hep.22479. Hepatology. 2008. PMID: 18756479 No abstract available.
Similar articles
-
Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.Gastroenterology. 2010 Aug;139(2):474-82. doi: 10.1053/j.gastro.2010.04.048. Epub 2010 Apr 29. Gastroenterology. 2010. PMID: 20434450
-
Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.Eur J Gastroenterol Hepatol. 2012 Apr;24(4):414-8. doi: 10.1097/MEG.0b013e328350594d. Eur J Gastroenterol Hepatol. 2012. PMID: 22273987
-
Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.Am J Gastroenterol. 2010 May;105(5):1102-9. doi: 10.1038/ajg.2009.669. Epub 2010 Mar 2. Am J Gastroenterol. 2010. PMID: 20197760
-
Hepatitis B surface antigen seroclearance during chronic HBV infection.Antivir Ther. 2010;15(2):133-43. doi: 10.3851/IMP1497. Antivir Ther. 2010. PMID: 20386068 Review.
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
Cited by
-
Molecular mechanisms underlying occult hepatitis B virus infection.Clin Microbiol Rev. 2012 Jan;25(1):142-63. doi: 10.1128/CMR.00018-11. Clin Microbiol Rev. 2012. PMID: 22232374 Free PMC article. Review.
-
Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.Clin Exp Immunol. 2012 Feb;167(2):296-302. doi: 10.1111/j.1365-2249.2011.04497.x. Clin Exp Immunol. 2012. PMID: 22236006 Free PMC article.
-
Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.PLoS Med. 2014 Dec 30;11(12):e1001774. doi: 10.1371/journal.pmed.1001774. eCollection 2014 Dec. PLoS Med. 2014. PMID: 25549238 Free PMC article. Clinical Trial.
-
Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA.Precis Clin Med. 2022 Nov 29;5(4):pbac030. doi: 10.1093/pcmedi/pbac030. eCollection 2022 Dec. Precis Clin Med. 2022. PMID: 36519139 Free PMC article.
-
Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China.Chin Med J (Engl). 2023 Nov 20;136(22):2686-2693. doi: 10.1097/CM9.0000000000002886. Epub 2023 Oct 25. Chin Med J (Engl). 2023. PMID: 37881959 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources